{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:03:36Z","timestamp":1789506216370,"version":"build-2803163510"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.prro.2026.09.004","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:20:39Z","timestamp":1789453239000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exacerbation of focal hepatotoxicity with Axitinib after Stereotactic Body Radiotherapy (SBRT) to malignant Renal mass in close proximity to Liver and resolution after short term drug holiday: Possible radio-sensitization effect"],"prefix":"10.1016","author":[{"given":"Shyam Singh","family":"Bisht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9245-1121","authenticated-orcid":false,"given":"Ayushee","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dheeraj","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S P","family":"Kataria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorun","family":"Shihsak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susovan","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kushal","family":"Narang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayur","family":"Mayank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejinder","family":"Kataria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.prro.2026.09.004_bib0001","first-page":"418","article-title":"Axitinib in sequential therapy in metastatic renal cell carcinoma","volume":"20","author":"Kuchar","year":"2016","journal-title":"Contemp Oncol"},{"issue":"1","key":"10.1016\/j.prro.2026.09.004_bib0002","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(23)00513-2","article-title":"Stereotactic body radiotherapy for primary renal cell carcinoma: a systematic review and practice guideline from the International Society of Stereotactic Radiosurgery (ISRS)","volume":"25","author":"Siva","year":"2024","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.prro.2026.09.004_bib0003","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1470-2045(24)00020-2","article-title":"Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial","volume":"25","author":"Siva","year":"2024","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.prro.2026.09.004_bib0004","doi-asserted-by":"crossref","first-page":"22678","DOI":"10.3390\/ijms141122678","article-title":"Membrane signaling induced by high doses of ionizing radiation in the endothelial compartment. Relevance in radiation toxicity","volume":"14","author":"Corre","year":"2013","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.prro.2026.09.004_bib0005","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1590\/s1677-5538.ibju.2017.0315","article-title":"Efficacy of targeted therapy for advanced renal cell carcinoma: A systematic review and meta-analysis of randomized controlled trials","volume":"44","author":"Wei","year":"2018","journal-title":"Int Braz J Urol"},{"issue":"1","key":"10.1016\/j.prro.2026.09.004_bib0006","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.radonc.2014.02.010","article-title":"Axitinib sensitization of high Single Dose Radiotherapy","volume":"111","author":"Rao","year":"2014","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.prro.2026.09.004_bib0007","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1016\/j.ijrobp.2007.07.294","article-title":"Radiation Necrosis After Stereotactic Radiosurgery for Metastatic Brain Disease","volume":"69","author":"Xu","year":"2007","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.prro.2026.09.004_bib0008","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fonc.2020.00012","article-title":"Tyrosine Kinase Inhibitor Resistance Increased the Risk of Cerebral Radiation Necrosis After Stereotactic Radiosurgery in Brain Metastases of Non-small-Cell Lung Cancer: A Multi-Institutional Retrospective Case-Control Study","volume":"10","author":"Zhuang","year":"2020","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.prro.2026.09.004_bib0009","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11060-017-2442-8","article-title":"The risk of radiation necrosis following stereotactic radiosurgery with concurrent systemic therapies","volume":"133","author":"Kim","year":"2017","journal-title":"J Neurooncol"},{"issue":"3","key":"10.1016\/j.prro.2026.09.004_bib0010","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijrobp.2015.02.016","article-title":"Gastrointestinal Toxicities With Combined Antiangiogenic and Stereotactic Body Radiation Therapy","volume":"92","author":"Pollom","year":"2015","journal-title":"Int J Radiat Oncol"},{"issue":"3","key":"10.1016\/j.prro.2026.09.004_bib0011","first-page":"236","article-title":"The tolerance of gastrointestinal organs to stereotactic body radiation therapy: what do we know so far?","volume":"5","author":"Thomas","year":"2014","journal-title":"\u80c3\u80a0\u80bf\u7624\u6742\u5fd7"},{"issue":"5","key":"10.1016\/j.prro.2026.09.004_bib0012","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.ijrobp.2005.12.004","article-title":"Increased risk of ischemic bowel complications during treatment with bevacizumab after pelvic irradiation: Report of three cases","volume":"64","author":"Lordick","year":"2006","journal-title":"Int J Radiat Oncol"},{"issue":"1","key":"10.1016\/j.prro.2026.09.004_bib0013","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijrobp.2013.05.012","article-title":"Increased Bowel Toxicity in Patients Treated With a Vascular Endothelial Growth Factor Inhibitor (VEGFI) After Stereotactic Body Radiation Therapy (SBRT)","volume":"87","author":"Barney","year":"2013","journal-title":"Int J Radiat Oncol"},{"issue":"1","key":"10.1016\/j.prro.2026.09.004_bib0014","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijrobp.2014.05.011","article-title":"Esophageal Dose Tolerance to Hypofractionated Stereotactic Body Radiation Therapy: Risk Factors for Late Toxicity","volume":"90","author":"Stephans","year":"2014","journal-title":"Int J Radiat Oncol"},{"issue":"2","key":"10.1016\/j.prro.2026.09.004_bib0015","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamaoncol.2024.5403","article-title":"Stereotactic Body Radiotherapy vs Sorafenib Alone in Hepatocellular Carcinoma: The NRG Oncology\/RTOG 1112 Phase 3 Randomized Clinical Trial","volume":"11","author":"Dawson","year":"2025","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.prro.2026.09.004_bib0016","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12943-019-0950-1","article-title":"Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues","volume":"18","author":"Zhuang","year":"2019","journal-title":"Mol Cancer"},{"issue":"3","key":"10.1016\/j.prro.2026.09.004_bib0017","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1345\/aph.1E186","article-title":"Role of Pentoxifylline and Vitamin E in Attenuation of Radiation-Induced Fibrosis","volume":"39","author":"Chiao","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.prro.2026.09.004_bib0018","doi-asserted-by":"crossref","unstructured":"Patel JS, Salari E, Chen X, Switchenko J, Eaton BR, Zhong J, et al. Radiomic Analysis of Treatment Effect for Patients with Radiation Necrosis Treated with Pentoxifylline and Vitamin E. Tomography. 2024 Sep 9;10(9):1501\u201312. doi:10.3390\/tomography10090110","DOI":"10.3390\/tomography10090110"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850026002845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850026002845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:07:53Z","timestamp":1789502873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850026002845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":18,"alternative-id":["S1879850026002845"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2026.09.004","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exacerbation of focal hepatotoxicity with Axitinib after Stereotactic Body Radiotherapy (SBRT) to malignant Renal mass in close proximity to Liver and resolution after short term drug holiday: Possible radio-sensitization effect","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2026.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Radiation Oncology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}